A clinical trials site in South Africa advancing HIV-related cervical cancer research
Official title: CAPRISA CASCADE Clinical Trials Network Clinical Research Site
Funded at Centre/aids Programme/res/south Africa · NIH-11413352 · Data updated 2026-11-12
A dedicated clinical trial site in KwaZulu-Natal, South Africa, is building infrastructure to run pragmatic trials addressing HIV and AIDS-related cervical cancer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Centre/aids Programme/res/south Africa NIH-funded |
| Lab location | 1 site (Durban, SOUTH AFRICA) |
| Project start | September 5, 2023 |
| Project end | May 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $91,242 |
| NIH project number | 5UG1CA284671-04 |
| Project ID | NIH-11413352 on NIH RePORTER |
Who could benefit from this research
✓Could help
Women living with HIV in KwaZulu-Natal, South Africa, and other eligible participants in CAPRISA CASCADE trials.
✕Less likely to help
Individuals not eligible for trial participation or not residing in the trial network may not benefit from this site-level infrastructure.
What this research studies
This grant supports CAPRISA CASCADE to provide trial sites, leadership, and operations for pragmatic clinical studies at an established research center in Durban. The site leverages its experience with HIV prevention and management to study cervical cancer in the context of HIV in a region heavily affected by both conditions. The team will recruit eligible participants, coordinate with a network of trial sites, and manage data collection to ensure rigorous, real-world results. The focus is on improving prevention, screening, and treatment pathways for women living with HIV who are at risk for or affected by cervical cancer.
Why it matters
Potential benefit: If successful, the work could improve access to effective HIV-related cervical cancer prevention and care for women in high-burden settings.
How similar studies have gone: CAPRISA has a long track record in HIV-related research and has conducted high-quality clinical trials, suggesting potential for successful pragmas.
Where this research is happening
-
Centre/aids Programme/res/south Africa
Durban, South Africa Active
Researchers
- Principal investigator: Naicker, Nivashnee — Centre/aids Programme/res/south Africa
- Study coordinator: Naicker, Nivashnee
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.